LYC Healthcare Berhad (KLSE:LYC)

Market Cap	14.80M
Revenue (ttm)	153.53M
Net Income (ttm)	-17.39M
Shares Out	739.95M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	149,000
Average Volume	440,320
Open	0.0200
Previous Close	0.0200
Day's Range	0.0150 - 0.0250
52-Week Range	0.0100 - 0.1150
Beta	0.27
RSI	32.27
Earnings Date	Aug 28, 2025

About Revance Therapeutics

LYC Healthcare Berhad provides health care services primarily in Malaysia and Singapore. The company operates through three segments: Healthcare Services, Computing and Electronic Services, and Other segments. It engages in the provision of mother and child care related services, such as postnatal and postpartum care, post-delivery confinement care, and aesthetics; senior nursing home care and related services; healthcare related services; cosmetics related and medical aesthetic treatment services; dental treatment and consultancy; child daycar...

• Industry: Computer Processing and Data Preparation and Processing Services
• Founded: 1992
• Employees: 70
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: LYC

Financial Performance

In 2024, LYC Healthcare Berhad's revenue was 153.53 million, an increase of 17.93% compared to the previous year's 130.19 million. Losses were -17.39 million, -9.23% less than in 2023.